ArticleJournal of oral and maxillofacial pathology : JOMFP2025
Challenges in delineating B-cell lymphoma: A case of plasmablastic lymphoma mimicking Burkitt lymphoma.
Article in Journal of oral and maxillofacial pathology : JOMFP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An immunocompromised body state following the human immunodeficiency virus (HIV) infection increases the risk of certain cancers like Kaposi sarcoma and lymphoma. B-cell lymphomas are the common neoplasms that occur, and Oral Plasmablastic lymphoma is one of its types. It is categorized as a large B-cell lymphoma and an aggressive type of non-Hodgkin lymphoma. These are rare tumours that histologically resemble other lymphomas, like Burkitt lymphoma, causing a diagnostic dilemma for pathologists. Here we report a rare case of Oral Plasmablastic lymphoma in a 32-year-old HIV-positive male with tuberculosis infection. Immunohistochemistry (IHC) was performed to confirm the diagnosis, and the markers used for differentiating various lymphomas have been discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.